Gsa Capital Partners LLP Nuvectis Pharma, Inc. Put Options Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVCT
# of Institutions
50Shares Held
3.2MCall Options Held
116KPut Options Held
87.6K-
Vanguard Group Inc Valley Forge, PA667KShares$4.55 Million0.0% of portfolio
-
Ronit Capital LLP563KShares$3.84 Million5.37% of portfolio
-
Baldwin Brothers LLC350KShares$2.39 Million0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA285KShares$1.95 Million0.0% of portfolio
-
Iridian Asset Management LLC254KShares$1.73 Million0.82% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $100M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...